JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
1.87 HKD
1.63%
Market Closed
Updated:
May 9, 2024
JW (Cayman) Therapeutics Co Ltd
Research & Development
|
JW (Cayman) Therapeutics Co Ltd
Research & Development Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Research & Development
-¥413.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Research & Development
-¥10.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Research & Development
-¥2.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Research & Development
-¥895.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-83%
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Research & Development
-¥168.2m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Research & Development?
Research & Development
-413.6m
CNY
-413.6m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Research & Development amounts to -413.6m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-41%
-41%
Over the last year, the Research & Development growth was -13%. The average annual Research & Development growth rates for JW (Cayman) Therapeutics Co Ltd have been -25% over the past three years , -41% over the past five years .
You don't have any saved screeners yet
